P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice

被引:37
|
作者
Guns, Pieter-Jan D. F. [1 ]
Hendrickx, Jan [1 ]
Van Assche, Tim [1 ]
Fransen, Paul [1 ]
Bult, Hidde [1 ]
机构
[1] Univ Antwerp, CDE, Div Pharmacol, B-2610 Antwerp, Belgium
关键词
atherosclerosis; apoE; P2Y(6); P2Y(2); gene expression; macrophage; suramin; PPADS; SMOOTH-MUSCLE-CELLS; DOUBLE-KNOCKOUT MICE; ENDOTHELIAL-CELLS; NUCLEOTIDE RECEPTORS; EXPRESSION; SURAMIN; GROWTH; MOUSE; UDP; LIPOPOLYSACCHARIDE;
D O I
10.1111/j.1476-5381.2009.00497.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: P2Y nucleotide receptors are involved in the regulation of vascular tone, smooth muscle cell (SMC) proliferation and inflammatory responses. The present study investigated whether they are involved in atherosclerosis. Experimental approach: mRNA of P2Y receptors was quantified (RT-PCR) in atherosclerotic and plaque-free aorta segments of apolipoprotein E-deficient (apoE(-/-)) mice. Macrophage activation was assessed in J774 macrophages, and effects of non-selective purinoceptor antagonists on atherosclerosis were evaluated in cholesterol-fed apoE(-/-) mice. Key results: P2Y(6) receptor mRNA was consistently elevated in segments with atherosclerosis, whereas P2Y(2) receptor expression remained unchanged. Expression of P2Y(1) or P2Y(4) receptor mRNA was low or undetectable, and not influenced by atherosclerosis. P2Y(6) mRNA expression was higher in cultured J774 macrophages than in cultured aortic SMCs. Furthermore, immunohistochemical staining of plaques demonstrated P2Y(6)-positive macrophages, but few SMCs, suggesting that macrophage recruitment accounted for the increase in P2Y(6) receptor mRNA during atherosclerosis. In contrast to ATP, the P2Y(6)-selective agonist UDP increased mRNA expression and activity of inducible nitric oxide synthase and interleukin-6 in J774 macrophages; this effect was blocked by suramin (100-300 mu M) or pyridoxal-phosphate-6-azophenyl-2'-4'-disulphonic acid (PPADS, 10-30 mu M). Finally, 4-week treatment of cholesterol-fed apoE(-/-) mice with suramin or PPADS (50 and 25 mg.kg(-1).day(-1) respectively) reduced plaque size, without changing plaque composition (relative SMC and macrophage content) or cell replication. Conclusions and implications: These results suggest involvement of nucleotide receptors, particularly P2Y(6) receptors, during atherosclerosis, and warrant further research with selective purinoceptor antagonists or P2Y(6) receptor-deficient mice. British Journal of Pharmacology (2010) 159, 326-336; doi: 10.1111/j.1476-5381.2009.00497.x; published online 24 December 2009
引用
收藏
页码:326 / 336
页数:11
相关论文
共 50 条
  • [31] Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice
    Bodary, PF
    Gu, SF
    Shen, YC
    Hasty, AH
    Buckler, JM
    Eitzman, DT
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) : 119 - 122
  • [32] Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice
    Matsui, Y
    Rittling, SR
    Okamoto, H
    Inobe, M
    Jia, N
    Shimizu, T
    Akino, M
    Sugawara, T
    Morimoto, J
    Kimura, C
    Kon, S
    Denhardt, D
    Kitabatake, A
    Uede, T
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (06) : 1029 - 1034
  • [33] Loss of lysophospholipase 3 increases atherosclerosis in apolipoprotein E-deficient mice
    Taniyama, Y
    Fuse, H
    Satomi, T
    Tozawa, R
    Yasuhara, Y
    Shimakawa, K
    Shibata, S
    Hattori, M
    Nakata, M
    Taketomi, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 330 (01) : 104 - 110
  • [34] Diesel Exhaust Particles Promote Atherosclerosis in Apolipoprotein E-Deficient Mice
    Miller, Mark R.
    McLean, Steven G.
    Duffin, Rodger
    Shaw, Catherine A.
    Mills, Nicholas L.
    Donaldson, Kenneth
    Newby, David E.
    Hadoke, Patrick W.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E292 - E293
  • [35] Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
    Lin, RY
    Choudhury, RP
    Cai, WJ
    Lu, M
    Fallon, JT
    Fisher, EA
    Vlassara, H
    ATHEROSCLEROSIS, 2003, 168 (02) : 213 - 220
  • [36] Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice
    Liu, Cong-Lin
    Wang, Yi
    Liao, Mengyang
    Santos, Marcela M.
    Fernandes, Cleverson
    Sukhova, Galina K.
    Zhang, Jin-Ying
    Cheng, Xiang
    Yang, Chongzhe
    Huang, Xiaozhu
    Levy, Bruce
    Libby, Peter
    Wu, Gongxiong
    Shi, Guo-Ping
    TRANSLATIONAL RESEARCH, 2016, 171 : 1 - 16
  • [37] Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice
    Nigro, Patrizia
    Satoh, Kimio
    O'Dell, Michael R.
    Soe, Nwe Nwe
    Cui, Zhaoqiang
    Mohan, Amy
    Abe, Jun-ichi
    Alexis, Jeffrey D.
    Sparks, Janet D.
    Berk, Bradford C.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (01): : 53 - 66
  • [38] Functional blockage of EMMPRIN ameliorates atherosclerosis in apolipoprotein E-deficient mice
    Liu, Hong
    Yang, Li-xia
    Guo, Rui-wei
    Zhu, Guo-Fu
    Shi, Yan-Kun
    Wang, Xian-mei
    Qi, Feng
    Guo, Chuan-ming
    Ye, Jin-shan
    Yang, Zhi-hua
    Liang, Xing
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 3248 - 3253
  • [39] Atherosclerosis in apolipoprotein E-deficient mice is attenuated by enterally given insulin
    Shamir, R
    Hayek, T
    Coleman, R
    Kaplan, M
    Lischinsky, S
    Diamond, E
    Shehadeh, N
    GASTROENTEROLOGY, 2001, 120 (05) : A677 - A677
  • [40] Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice
    Wang, Wen-Jun
    Baez, Juan M.
    Maurer, Rie
    Dansky, Hayes M.
    Cohen, David E.
    JOURNAL OF LIPID RESEARCH, 2006, 47 (11) : 2400 - 2407